# The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy

> **NCT00864773** · NA · UNKNOWN · sponsor: **Hallym University Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Central Serous Chorioretinopathy

## Interventions

- **PROCEDURE:** intravitreal injection with anterior paracentesis

## Key facts

- **NCT ID:** NCT00864773
- **Lead sponsor:** Hallym University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2009-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864773, "The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00864773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*